Loading…
Benitec Biopharma Inc. is projected to rise to $14.87 by 2027, a +27% move from its current price of $11.71. BNTC is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/2/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 3 | $11.44 | $11.71 | $11.99 | +0.04% |
| Aug 4 | $11.34 | $11.72 | $12.11 | +0.08% |
| Aug 5 | $11.26 | $11.72 | $12.21 | +0.11% |
| Aug 6 | $11.19 | $11.73 | $12.29 | +0.15% |
| Aug 7 | $11.13 | $11.73 | $12.36 | +0.19% |
| Aug 8 | $11.08 | $11.74 | $12.43 | +0.23% |
| Aug 9 | $11.04 | $11.74 | $12.49 | +0.26% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $11.04 | $11.74 | $12.49 | +0.26% |
| Week 2 | $10.78 | $11.77 | $12.85 | +0.53% |
| Week 3 | $10.60 | $11.80 | $13.14 | +0.80% |
| Week 4 | $10.46 | $11.83 | $13.40 | +1.06% |
| Week 5 | $10.33 | $11.87 | $13.63 | +1.33% |
| Week 6 | $10.22 | $11.90 | $13.85 | +1.60% |
| Week 7 | $10.13 | $11.93 | $14.05 | +1.87% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the development of novel genetic medicines.
Its Silence and Replace platform combines RNA interference with gene therapy to create medicines that silence disease-causing genes and deliver wildtype replacement genes after a single administration.
The company is developing BB-301, an AAV-based gene therapy designed to silence the expression of the disease-causing gene for the treatment of oculopharyngeal muscular dystrophy related dysphagia; it is headquartered in Hayward, California.
Benitec Biopharma Inc. (BNTC) operates in the Healthcare sector.
The current price is $11.97 and the market cap is $411.22M, with a rank of 3024.
From 2026 to 2050, the average forecast climbs from $11.97 to $117.41, with significant upside and a bullish sentiment starting in 2027. The forecast also shows a max price path rising to $219.62 by 2050.
Overall, the outlook suggests meaningful upside in the long run, with steady year-over-year increases in the projected average price across multiple future years.
A major floor 14.1% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.3% away) — a key level to hold.
The nearest ceiling, 16.4% above — a clean break opens room to run.
A major ceiling 23.4% above — clearing it would confirm fresh momentum.
Key BNTC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of BNTC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $11.82 | Sell | $11.80 | Sell |
| MA 10 | $11.73 | Sell | $11.92 | Sell |
| MA 20 | $12.44 | Sell | $12.12 | Sell |
| MA 50 | $11.97 | Sell | $12.12 | Sell |
| MA 100 | $11.91 | Sell | $12.07 | Sell |
| MA 200 | $12.37 | Sell | $12.18 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.95 | Neutral |
| Stoch RSI (14) | 29.66 | Neutral |
| CCI (20) | -68.55 | Neutral |
| Williams %R (14) | -82.91 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -10.06 | Sell |
| Bollinger %B (20,2) | 0.26 | Neutral |
| Stochastic %K (14) | 17.09 | Buy |
| TRIX (15) | -0.06 | Sell |
| Awesome (5,34) | -0.61 | Sell |
| Ultimate (7,14,28) | 51.14 | Neutral |
| Momentum (10) | -1.07 | Sell |
| Aroon Osc (25) | -40.00 | Sell |
| Hull MA (9) | 11.97 | Sell |
| ADX (14) | 15.44 | Neutral |
| ATR (14) | 0.24 | Info |
The 30-day technical picture is NEUTRAL.
RSI14 is 40, with the 50-day simple moving average at $11.96 and the 200-day simple moving average at $12.48.
Support is listed at $10.39 and resistance at $13.63, with a 30-day price range from $9.94 to $14.42.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $10.06 | $11.71 | $15.87 | 0% | Neutral | |
| $12.01 | $14.87 | $19.36 | +27% | Bullish | |
| $15.20 | $19.26 | $25.92 | +65% | Bullish | |
| $17.11 | $22.12 | $30.54 | +89% | Bullish | |
| $17.62 | $23.17 | $32.69 | +98% | Bullish | |
| $19.48 | $26.03 | $37.42 | +122% | Bullish | |
| $20.57 | $27.88 | $40.77 | +138% | Bullish | |
| $21.59 | $29.66 | $44.05 | +153% | Bullish | |
| $24.86 | $34.60 | $52.11 | +195% | Bullish | |
| $29.34 | $41.34 | $63.09 | +253% | Bullish | |
| $37.15 | $55.31 | $89.22 | +372% | Bullish | |
| $79.72 | $130.27 | $227.93 | +10.1x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $10.06 | $11.71 | $14.50 | +0.00% |
| September 2026 | $10.46 | $12.32 | $14.89 | +5.25% |
| October 2026 | $10.23 | $12.12 | $14.78 | -1.65% |
| November 2026 | $10.34 | $12.31 | $15.12 | +1.56% |
| December 2026 | $10.73 | $12.83 | $15.87 | +4.23% |
Click any year to see its month-by-month BNTC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The BNTC price prediction for 2026 points to an average of $11.71 (low $10.06, high $15.87) — a potential gain of 0% on today's $11.71. Price action looks broadly range-bound.
In 2027, BNTC is projected to trade between $12.01 and $19.36, averaging $14.87 — a potential gain of +27% from today's $11.71. That is up +27% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Benitec Biopharma Inc.'s 2028 outlook centres on $19.26, within a $15.20 to $25.92 range. That is up +30% on the projected 2027 average. That marks a +65% change versus current levels. Momentum favours further upside here.
By 2029, BNTC could reach as high as $30.54, with a base case around $22.12 and support toward $17.11 — roughly +89% from $11.71. Buyers look set to stay in control over this stretch.
Expect BNTC to range from $17.62 to $32.69 through 2030. The $23.17 average target implies a +98% move from current prices. That is up +5% on the projected 2029 average. Momentum favours further upside here.
The BNTC price prediction for 2031 points to an average of $26.03 (low $19.48, high $37.42) — a potential gain of +122% on today's $11.71. Buyers look set to stay in control over this stretch.
In 2032, BNTC is projected to trade between $20.57 and $40.77, averaging $27.88 — a potential gain of +138% from today's $11.71. That is up +7% on the projected 2031 average. Momentum favours further upside here.
Benitec Biopharma Inc.'s 2033 outlook centres on $29.66, within a $21.59 to $44.05 range. That is up +6% on the projected 2032 average. That marks a +153% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, BNTC could reach as high as $52.11, with a base case around $34.60 and support toward $24.86 — roughly +195% from $11.71. Momentum favours further upside here.
Expect BNTC to range from $29.34 to $63.09 through 2035. The $41.34 average target implies a +253% move from current prices. That is up +19% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The BNTC price prediction for 2040 points to an average of $55.31 (low $37.15, high $89.22) — a potential gain of +372% on today's $11.71. Momentum favours further upside here.
In 2050, BNTC is projected to trade between $79.72 and $227.93, averaging $130.27 — a potential gain of +10.1x from today's $11.71. That is up +136% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in BNTC today (≈ 85.397096 BNTC) could be worth
$11,124.48
+$10,124.48 (+1012%) by 2050 · US Dollar
Based on the average projected BNTC price of $130.27 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in BNTCwould be worth at today's price.
$1,000 invested in BNTC on Jul 31, 2025 (≈ 91.491306 BNTC) would be worth
$1,071.36
+$71.36 (+7.1%) today · 1.07× · US Dollar
Based on a BNTC entry price of $10.93 vs. today's $11.71.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $11.47 | $1,020.92 | +2.1% |
| 1 month ago | $12.69 | $922.77 | -7.7% |
| 3 months ago | $11.95 | $979.92 | -2.0% |
| 6 months ago | $12.46 | $939.81 | -6.0% |
| 1 year ago | $10.93 | $1,071.36 | +7.1% |
| All time (5.0y) ago | $60.35 | $194.03 | -80.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our BNTC forecast.
Our base-case forecast reaches $23.00 around 2030.
Implied market cap at $23.00: $790.15M
The multi-year forecast shows a bullish sentiment from 2027 onward, with a rising path of average prices and rising ROI.
For 2026, the min/avg/max forecast are $10.06, $11.97, and $16.55 with ROI 0 and a NEUTRAL sentiment. By 2027, the avg price is $14.80 with ROI 23.6 and a BULLISH stance; 2028 shows avg $19.66 and ROI 64.2; 2029 shows avg $22.20 and ROI 85.5; 2030 shows avg $22.45 and ROI 87.5.
Beyond 2030, the forecast remains bullish: 2031 avg $25.61 (ROI 114), 2032 avg $26.52 (121.5), 2033 avg $27.11 (126.5), 2034 avg $32.74 (173.6), 2035 avg $39.09 (226.5), 2040 avg $50.12 (318.7), and 2050 avg $117.41 (880.9).
These projections imply substantial upside over the long term, but they are estimates and not guarantees, subject to market conditions and other inherent risks.
Tap a question to reveal the answer.
2030 Avg price $22.45; min $16.55; max $32.84; ROI 87.5%; sentiment BULLISH.
Forecasts indicate a bullish path from 2027 onward, with rising average prices and ROI (e.g., 2027 avg $14.80, 2030 avg $22.45 and ROI 87.5%). These are estimates and not guarantees.
Yes, the 2050 max is $219.62, which exceeds $100, while earlier years have lower max values (e.g., 2040 max $85.52, 2035 max $62.60). This suggests potential to exceed $100 over the forecast horizon.
Current price $11.97; Market cap $411.22M.
RSI 14 is 40. Sentiment NEUTRAL. SMA50 is $11.96; SMA200 is $12.48. Support at $10.39 and resistance at $13.63; 30-day range $9.94–$14.42.
Benitec Biopharma Inc. Community Discussion
0Share your Benitec Biopharma Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.